ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,871Medicare Part D Prescriptions Filled, Including Refills

Rank: 310 out of 1844

$515K Total Retail Price of All Prescriptions

Rank: 333 out of 1844

419 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 419 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 419 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

0% of this provider’s 5,359 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
FUROSEMIDE 353 197 1 7
HYDROCODONE-ACETAMINOPHEN 326 135 S3 2 2
LEVOTHYROXINE SODIUM 302 195 3 1
PRAVASTATIN SODIUM 288 156 4 10
LISINOPRIL 270 111 5 4
POTASSIUM CHLORIDE 236 182 6 16
METFORMIN HCL 201 114 7 8
SIMVASTATIN 186 98 8 3
OMEPRAZOLE 184 102 9 5
DONEPEZIL HCL 179 177 10 26
NAMENDA 169 158 11 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 166 136 12 20
AMLODIPINE BESYLATE 147 107 13 6
TRAMADOL HCL 133 94 14 18
POLYETHYLENE GLYCOL 3350 122 110 15 39
METOPROLOL TARTRATE 115 62 16 11
ATENOLOL 108 81 17 17
GABAPENTIN 108 30 17 15
CITALOPRAM HBR 97 64 19 19
ALENDRONATE SODIUM 93 65 20 25
WARFARIN SODIUM 93 75 20 13
CLOPIDOGREL 91 41 22 34
METOPROLOL SUCCINATE 82 77 23 14
SPIRONOLACTONE 79 37 24 60
VERAPAMIL ER 78 51 25 98
LANTUS 78 34 25 42
SERTRALINE HCL 78 39 25 21
MIRTAZAPINE 77 69 28 49
DIVALPROEX SODIUM 75 61 29 74
CARVEDILOL 75 50 29 22
OXYBUTYNIN CHLORIDE 74 34 31 103
TRAZODONE HCL 73 40 32 43
TRICOR 72 28 33 109
ATORVASTATIN CALCIUM 72 48 33 12
AZITHROMYCIN 64 33 35 37
IPRATROPIUM-ALBUTEROL 63 50 36 113
PREDNISONE 62 24 37 40
PLAVIX 61 36 38 61
GEMFIBROZIL 59 35 39 108
CRESTOR 58 34 40 30
KLOR-CON M20 57 33 41 54
CLONIDINE HCL 57 22 41 64
NYSTATIN 56 34 43 85
TIZANIDINE HCL 55 28 44 141
METHYLPREDNISOLONE 54 35 45 125
ALLOPURINOL 54 44 45 29
TAMSULOSIN HCL 54 37 45 27
ESCITALOPRAM OXALATE 54 41 45 52
CYMBALTA 53 29 49 36
TRIAMTERENE-HCTZ 53 53 49 48
ADVAIR DISKUS 53 18 49 51
LOSARTAN-HYDROCHLOROTHIAZIDE 50 29 52 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 24, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.